← Signals · Healthcare · TSX
$APTX
Apotex Health Corp.
Signal as of September 24, 2026  ·  90-day rolling window  ·  Pharmaceuticals
Confluence Score
55
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 40–59 have historically hit 41% of the time (avg +7.1% over 90 days, 4424 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
📅 Buying into earnings — Nov 11 (41d)
Confluence Score
55
Insider Activity (90d)
3
3 buyers  ·  $850.0M  ·  open-market only
Current Price
$31.13
CAD  ·  5-min cache
Market Cap
$7.1B
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 56% hit rate · -2.8% alpha vs XIU.TO · 27 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSX:APTX
Insider Transactions
90-day window  ·  5 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Sep 18, 2026 SK Artemis Holdings II, LLC — Open Market Buy 19,252,009 $34.00 -8.4%  · 13d $654.6M
Sep 18, 2026 Oberman, Allan Grant — Exercise Sell 532,062 $0.01 — $5K
Sep 18, 2026 Oberman, Allan Grant — Exercise Buy 532,062 $0.01 +311200.0%  · 13d $5K
Sep 18, 2026 Oberman, Allan Grant — Open Market Buy 532,062 $34.00 -8.4%  · 13d $18.1M
Sep 18, 2026 API Investment LP — Open Market Buy 5,215,929 $34.00 -8.4%  · 13d $177.3M
Score uses open-market buys only  ·  3 open-market  ·  1 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 25 30 3 unique buyers
Buy/sell ratio 20 75% buys (3B / 1S)
Dollar value 25 $850.0M (large cap — noise penalised)
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 Loose cluster: 2+ insiders bought same-day or within ~2 weeks
Buy/sell reversal pattern 8 1 insider reversed from selling to buying
Total 55 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 3 unique buyers
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
SK Artemis Holdings II, LLC — — — — $654.6M Sep 18, 2026
API Investment LP — — — — $177.3M Sep 18, 2026
Oberman, Allan Grant — — — — $18.1M Sep 18, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for APTX.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Sep 15, 2026
Shares short
1,212,186
Net change
+199,978 (+19.8%)
History
Sep 15: 1,212,186
Aug 31: 1,012,208
Aug 15: 927,498
Jul 31: 675,570
Jul 15: 223,633
Jun 30: 321,464
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Boardroom Connections
2 insiders also active elsewhere
Insider Other boards Also an insider at
Firestone, Theresa 1 ACB (10)
Watson, Jeff 1 CRRX
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.